Table 1.
Case No. | Age (yr) | Sex | F/U interval (mo) | Initial diameter (mm) | F/U diameter (mm) | Histological diagnosis |
---|---|---|---|---|---|---|
1 | 62 | F | 22 | 15 | 11 | Nodular hyperplasia |
2 | 37 | F | 14 | 11 | 8 | Benign fibrotic nodule |
3 | 63 | M | 15 | 11 | 8 | Nodular hyperplasia |
4 | 54 | F | 16 | 19 | 14 | Nodular hyperplasia |
5 | 54 | F | 12 | 17 | 10 | Nodular hyperplasia |
6 | 59 | F | 34 | 17 | 11 | Nodular hyperplasia |
7 | 62 | M | 51 | 13 | 4 | Nodular hyperplasia |
8 | 33 | F | 12 | 16 | 3 | Organizing hematoma |
9 | 61 | F | 99 | 65 | 7 | Nodular hyperplasia |
10 | 61 | F | 53 | 13 | 9 | Nodular hyperplasia |
11 | 59 | F | 67 | 16 | 6 | Nodular hyperplasia |
12 | 61 | M | 30 | 24 | 12 | Nodular hyperplasia |
13 | 63 | F | 77 | 41 | 26 | Nodular hyperplasia with hematoma |
14 | 39 | M | 44 | 30 | 13 | Nodular hyperplasia |
15 | 61 | F | 47 | 13 | 8 | Nodular hyperplasia |
16 | 51 | M | 15 | 19 | 6 | Hurthle cell adenoma |
F/U, follow-up; F, female; M, male.